What is Acute Respiratory Distress Syndrome (ARDS)?
ARDS is a life-threatening lung condition characterized by rapid inflammation and fluid buildup in the alveoli, leading to severe oxygen deprivation. It commonly occurs after viral infections like influenza or COVID-19. The lungs become stiff, making breathing difficult and impairing oxygen exchange. Prompt diagnosis and respiratory support are critical for patient survival.
How Viral Infections Trigger ARDS and Shock
Certain viruses cause intense immune responses that damage lung tissue and blood vessels, resulting in ARDS. This inflammation can also disrupt blood circulation, leading to shock—a dangerous drop in blood pressure that limits oxygen delivery to vital organs. Viral invasions such as SARS-CoV-2 and H1N1 influenza are known triggers of these severe complications.
Symptoms and Diagnosis
Symptoms include severe shortness of breath, rapid breathing, low oxygen levels, and confusion. Shock signs include weak pulse, cold extremities, and altered consciousness. Diagnosis involves imaging like chest X-rays, blood tests, and monitoring oxygen saturation. Early detection allows intensive care interventions such as mechanical ventilation and fluid management.
Treatment and Prevention
Treatment focuses on supporting lung function and stabilizing circulation. Mechanical ventilation, oxygen therapy, and medications to manage inflammation and infection are standard. Preventive measures include vaccination, early antiviral therapy, and infection control practices to reduce viral transmission and the risk of ARDS and shock.